VCCT Inc.

About VCCT Inc.

VC Cell Therapy Inc. is a company focused on developing regenerative medicine solutions for intractable retinal outer layer diseases. As part of the Vision Care Group, a global leader in eye health, their mission is to create treatment methods for retinal diseases through innovative approaches in regenerative medicine, aiming to solve medical system issues by making sustainable healthcare successful. They are associated with the Kobe Eye Center, a pioneering facility integrating research, clinical application, and patient care.

Products & Services

RPE Cell Therapy:Advanced research in regenerative medicine focusing on Retinal Pigment Epithelium (RPE) cells using induced pluripotent stem (iPS) cells for treating age-related macular degeneration (AMD). Includes clinical studies on autologous and allogeneic RPE cell transplantation, and innovative techniques like the 'RPE strip' for minimally invasive, precise transplantation.

Photoreceptor Cell Regeneration:Development of treatments for photoreceptor cell dysfunction, a major cause of blindness in aging populations, using stem cell technology to create retinal organoids for transplantation. Clinical studies in partnership with Kobe Eye Center Hospital aim to confirm safety and efficacy.

Robotic Cell Manufacturing:Automation and enhancement of cell manufacturing processes using robotics and AI, in collaboration with Robotic Biology Institute Inc. Utilizes the LabDroid 'Mahoro' robot for clinical research at Kobe Eye Center Hospital to ensure high-quality, stable cell production.

Specialties

Regenerative Medicine Retinal Pigment Epithelium (RPE) Cell Therapy Photoreceptor Cell Regeneration iPS Cell Technology Robotic Cell Manufacturing Retinal Organoid Development Treatment for Age-Related Macular Degeneration (AMD) Treatment for Retinal Degenerative Diseases

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Equity Allotment T: - FT: Private Equity Allotment	A: 4000000 MR: - FA: 600 million Japanese yen FAN: 4000000	D: 2023-11-15 FD: 2023-11-15	3 investors

Private Equity Allotment Latest

2023-11-15

$4.0M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Masayo Takahashi

President and CEO

T

Takuma Fukuda

Director CFO

S

Seiji Hori

Director CTO

S

Shin Nakamura

Outside Director

Y

Yoshinori Nishikawa

Auditor

S

Shinya Yamanaka

Professor

View 4 more team members with Pro

Unlock Full Team Directory

Recent News

VCCT Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised